11/19
05:28 pm
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
11/19
10:42 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
11/19
09:31 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
11/19
09:13 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
11/19
08:20 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
11/19
05:30 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
11/19
05:30 am
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
11/18
07:40 pm
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $62.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $62.00 price target on the stock.
11/18
06:51 pm
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
11/11
04:56 pm
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $62.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $62.00 price target on the stock.
11/11
04:50 pm
rckt
Rating for RCKT
Medium
Report
Rating for RCKT
11/8
08:46 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
11/8
05:23 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
11/8
05:23 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
10/16
10:14 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
10/16
10:14 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
10/16
08:44 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
10/16
08:44 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating on the stock.
9/30
11:29 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
9/17
11:11 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $52.00 price target on the stock.
9/17
11:03 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT
9/17
11:03 am
rckt
Rating for RCKT
Low
Report
Rating for RCKT